A new report found that 9 of 10 small- to midsize businesses are not sure they will be able to provide health benefits to their employees in the near future.

An expert discusses the expanded treatment options for refractory ITP, emphasizing accurate diagnosis, combination therapies targeting platelet production and destruction, and the evolving role of ...

A panel held during the Institute for Value-Based Medicine event in Chicago on August 14, 2025, included discussions of ...

A new TIAA Institute report says solving workforce shortages with smarter hiring, training, and artificial intelligence could ...

Climate-related disasters threaten US drug production, highlighting vulnerabilities in the pharmaceutical supply chain and ...

AI enhances mammography by reducing radiologists' workload by 40% while maintaining accuracy in breast cancer detection, ...

Explore how payers and providers collaborate to enhance value-based care, tackle rising costs, and improve patient outcomes ...

New research reveals how triple-negative breast tumors use fatty tissue to fuel growth, highlighting the role of gap junctions in tumorigenesis.

In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing financial toxicity and logistical barriers.

James D. Chalmers, MBChB, PhD, explains that the ASPEN trial findings show that brensocatib reduces exacerbations, slows lung function decline at higher doses, and offers clinicians a long-awaited ...

Jonathan Thompson, MD, MS, highlighted that reducing delays in molecular testing and treatment initiation is critical for improving lung cancer outcomes, and that clinical trial data suggest ...

Jenny Craven, PharmD, BCPS, outlines the strategies UC Davis Health has used to successfully navigate the complex challenges of implementing cell and gene therapies.